Type to search

Hummingbird Bioscience to Collaborate with Merck on Clinical Trial of Anti-VISTA Antibody HMBD-002 in Combination with KEYTRUDA® (Pembrolizumab) for Treatment of Cancer | Pharmtech Focus
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Josh House as Chief Financial Officer | Pharmtech Focus
Hummingbird Bioscience Appoints Renowned Scientist and Medical Oncologist Dr. Thomas J. Lynch to its Board of Directors | Pharmtech Focus